S100A4 and glioma: An integrated analysis of 201,986 human glioma, immune, and other stromal cells confirmed heterogeneity of tumor microenvironment for gliomas and revealed S100A4 as a regulator of immune suppressive T and myeloid cells in glioblastoma (120).